Literature DB >> 7514816

Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.

K Minamikawa1, H Wada, Y Wakita, M Ohiwa, M Tanigawa, K Deguchi, N Hiraoka, H Huzioka, J Nishioka, T Hayashi.   

Abstract

Activated protein C (APC)-protein C inhibitor (PCI) complex level was examined in 35 patients with acute pulmonary embolism (PE) and in 20 healthy volunteers. Thrombin-antithrombin III complex, plasmin alpha 2 plasmin inhibitor complex, and fibrin-D-dimer levels were significantly increased in the patients with PE compared to levels in healthy volunteers. Levels of plasminogen activator inhibitor-I, tissue type plasminogen activator, and von Willebrand factor antigens were also significantly increased in patients with PE. Plasma level of APC-PCI complex was increased in most patients with PE and APC-alpha 1 antitrypsin complex level was increased in 13 patients. These complexes were not detected in healthy volunteers. These findings suggested that plasma protein C was activated in patients with PE, and that PCI was the major inhibitor of APC generated in this condition. Thus, regulation of the protein C pathway might play an important role in the pathogenesis of PE.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514816

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Authors:  Hideki Nomura; Hideo Wada; Toshiro Mizuno; Naoyuki Katayama; Yasunori Abe; Maki Noda; Kaname Nakatani; Takeshi Matsumoto; Satoshi Ota; Norikazu Yamada; Akihiro Sudo; Atsumasa Uchida; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-02-19       Impact factor: 2.490

2.  The diagnostic performance of APC-PCI complex determination compared to D-dimer in the diagnosis of deep vein thrombosis.

Authors:  Johan L Elf; Karin Strandberg; Peter J Svensson
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

3.  Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolism.

Authors:  John-Bjarne Hansen; José A Fernández; Knut H Borch; John H Griffin; Jan H Brox; Sigrid K Braekkan
Journal:  Thromb Res       Date:  2011-07-20       Impact factor: 3.944

4.  Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.

Authors:  Johan Undén; Karin Strandberg; Jan Malm; Eric Campbell; Lars Rosengren; Johan Stenflo; Bo Norrving; Bertil Romner; Arne Lindgren; Gunnar Andsberg
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

5.  Expression of vascular infarction-related molecules after anti-vascular endothelium growth factor treatment for diabetic macular edema.

Authors:  Masahiko Sugimoto; Yasuko Wakamatsu; Ryohei Miyata; Takayasu Nunome; Yumiho Tenma; Hisashi Matsubara; Mineo Kondo; Hideo Wada; Kaname Nakatani
Journal:  Sci Rep       Date:  2019-08-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.